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Discussion

A 55 yr old male with past medical history significant for end
stage liver disease, intravenous drug abuse and hypertension
presents to the ED with complaints of bright red blood per rectum
for the past 3 days and non-specific chest discomfort. Medications
on admission were amlodipine, valsartan /HCTZ, xanax,
terazosin, and high dose methadone maintenance therapy.

The long QT syndrome is a disorder of myocardial repolarization
characterized by a prolonged QT interval on the electrocardiogram. This syndrome is associated with an increased risk of a
characteristic life threatening cardiac arrhythmia known as
Torsades de pointes. Torsade de pointes is a form of polymorphic
ventricular tachycardia that occurs in the setting of acquired or
congenital QT interval prolongation. Polymorphic ventricular
tachycardia is defined as a ventricular rhythm faster than 100
beats/min with frequent variations of the QRS axis, morphology
or both. The peaks of the QRS complexes appear to twist around
the isoelectric line of recording; the name literally translates to
“twisting of the points.”

On admission, temperature was 98º F, heart rate was 50,
respiratory rate was 18, blood pressure was 122/75, and oxygen
saturation was 99% on room air. Physical examination was
normal. No bright red blood per rectum was noticed and stool
was heme-negative. Initial laboratory values including a complete
blood count and chemistry panel were within normal limits
inclucing a hemoglobin of 14.6, calcium of 9.6, potassium of 3.9,
and magnesium of 1.8. The patient was ruled out for myocardial
infarction with three negative troponins. The admission EKG is
presented below (Figure 1).
While in the ED on the day of admission, the patient was noticed
to have ventricular tachycardia on telemetry. He was
asymptomatic during the episode and his vital signs were stable.
The telemetry strip at that time is shown below (Figure 2).
The patient was given 2 grams magnesium in the and the patient
was admitted to the CCU. QT interval prolongation from high
dose methadone therapy was the most likely cause of his episode
of polymorphic ventricular tachycardia. Electrophysiology
consultation recommended that his methadone dose be decreased
so that his QT interval would be within normal limits. Prior to
discharge, his methadone dose had been lowered without any
symptoms of methadone withdrawal and his EKG on discharge is
shown below (Figure 3).
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The most common causes of acquired long QT interval syndrome
are either medication-induced or electrolyte abnormalities. Some
medications known to cause QT interval prolongation are antiarrhythmics such as quinidine, procainamide, disopyramide,
amiodarone, dofetilide, and ibutilide; antibiotics including
erythromycin, clarithromycin, and fluoroquinolones; antihistamines such as terfinadine and astemizole; the antipsychotic
agents chlorpromazine, haloperidol, and thioridazine; and high
dose methadone. Caution should be used when prescribing a drug
that prolongs QT interval in patients with risk factors; a baseline
EKG and daily EKGs should be obtained during the course of
therapy. There are various risk factors for drug induced torsades
including female sex, hypokalemia, hypomagnesemia,
bradycardia, rapid rate of intravenous infusion with a QT interval
prolonging drug, congestive heart failure, baseline QT interval
prolongation; sub clinical long QT interval prolongation, and ion
channel polymorphisms.
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Figure 3.
QT prolongation and torsade de pointes have been reported in
patients on high doses (100 to 400 mg) of methadone. Methadone
has a long plasma elimination half life and is metabolized by the
CYP3A4 enzyme system in the liver, so any drug which inhibits
the CYP3A4 enzyme system can increase methadone levels in the
blood. CYP3A4 inhibitors include antimicrobials, antifungals,
statins, and acetaminophen. Two mechanisms can explain the
association between methadone and torsade de pointes, synthetic
opoids cause bradycardia and they can inhibit the outward
potassium current during phase 3 of action potential.
In a retrospective analysis of reports of adverse events associated
with methadone from 1969 to 2002 found that out of a total of
5,503 adverse events associated with methadone, 43 (0.78%) were
reported to be torsades de pointes and an additional 16 were noted

to have QT prolongation. The dose reported was 410+/-349
mg/day (median 345 mg, range 29-1680) while only 10 cases
were within the recommended range for methadone maintenance
(60-100mg). Female gender, interacting medications,
hypokalemia, hypomagnesemia and structural heart disease were
found in 44 (75%) cases. Most adverse events required hospitalization (28/59) and death resulted in 5 cases.
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